Capital increase in connection with exercise of warrants
For both schemes the vesting period is three years, and both schemes can therefore be exercised in the trading window that opened on
Since
- 2015 scheme: One individual has issued instructions to exercise 15,000 warrants at the agreed exercise price of
DKK 39.26 per share with a nominal value ofDKK 0.50 . - 2016 scheme: Three individuals have issued instructions to exercise a total of 10,000 warrants at the agreed exercise price of
DKK 77.12 per share with a nominal value ofDKK 0.50 .
Today Ambu’s Board of Directors decided to carry out the capital increase relating to the exercised warrants.
As a result of the capital increase, the share capital of Ambu will be increased by a nominal amount of
Following this and in consideration of the employees having left the company, the following warrants remain under the said schemes:
- 2015 scheme: 100,000 remaining warrants being held by 10 individuals.
- 2016 scheme: 232,000 remaining warrants being held by 42 individuals.
The new B shares are expected to be admitted to trading and official listing on
Under section 32 of the Danish Capital Markets Act,
Number of shares (nominal value | Nominal value (DKK) | Voting rights | |
A shares | 34,320,000 | 17,160,000 | 343,200,000 |
B shares | 218,522,100 | 109,261,050 | 218,522,100 |
Total | 252,842,100 | 126,421,050 | 561,722,100 |
Contact
Michael Højgaard, CFO, tel. +45 4030 4349, email: miho@ambu.com
Baltorpbakken 13
2750 Ballerup,
Tel. +45 7225 2000
CVR no.: 63 64 49 19
www.ambu.com
About Ambu
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ – the world’s first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near
Attachment
- 19112020 Company_Announcement_no. 4 2020_21
© OMX, source